Share Email Print
cover

Proceedings Paper

Fluorescence observations of patients in the course of photodynamic therapy of cancer with the photosensitizer PHOTOSENS
Author(s): Natalia N. Zharkova; Dmitrij N. Kozlov; V. V. Smirnov; Victor V. Sokolov; Valery I. Chissov; E. V. Filonenko; Garry M. Sukhin; Maria G. Galpern; Georgy N. Vorozhtsov
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

In the course of clinical trials of Photosens (Al-sulphonated phthalocyanine) as a new drug for PDT of cancer fluorescence observations of patients with injected photosensitizer are performed. The aim of current investigations is to develop the clinical method of cancer diagnostics with Photosens, to study the pharmaco-kinetics of the drug in the human body and its retention in tumors.

Paper Details

Date Published: 12 January 1995
PDF: 4 pages
Proc. SPIE 2325, Photodynamic Therapy of Cancer II, (12 January 1995); doi: 10.1117/12.199176
Show Author Affiliations
Natalia N. Zharkova, General Physics Institute (Russia)
Dmitrij N. Kozlov, General Physics Institute (Russia)
V. V. Smirnov, General Physics Institute (Russia)
Victor V. Sokolov, P.A. Hertzen Moscow Research Oncology Institute (Russia)
Valery I. Chissov, P.A. Hertzen Moscow Research Oncology Institute (Russia)
E. V. Filonenko, P.A. Hertzen Moscow Research Oncology Institute (Russia)
Garry M. Sukhin, P.A. Hertzen Moscow Research Oncology Institute (Russia)
Maria G. Galpern, Moscow Research Institute of Organic Intermediates and Dyes (Russia)
Georgy N. Vorozhtsov, Moscow Research Institute of Organic Intermediates and Dyes (Russia)


Published in SPIE Proceedings Vol. 2325:
Photodynamic Therapy of Cancer II
Daniel Brault; Giulio Jori; Johan Moan; Benjamin Ehrenberg, Editor(s)

© SPIE. Terms of Use
Back to Top